Trans-R-138727
Trans-R-138727 is the trans isomer of R-138727 (HY-123669) . R-138727 is the active metabolite of the antiplatelet agent Prasugrel (HY-15284) . R-138727 is an irreversible inhibitor for the platelet receptor P2Y12, and inhibits ADP-induced platelet activation and aggregation[1].
Product Specifications
CAS Number
[239466-74-1]
UNSPSC
12352005
Target
P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/trans-r-138727.html
Purity
98.98
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)/C=C1CN(C(C2=CC=CC=C2F)C(C3CC3)=O)CCC\1S
Molecular Formula
C18H20FNO3S
Molecular Weight
349.42
References & Citations
[1]Hasegawa M, et al. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor. Thromb Haemost. 2005 Sep;94 (3) :593-8.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RPC29806-02 100 µg
Recombinant Human Myc proto-oncogene protein (MYC), Biotinylated
Ask
View Details 
040421-AP 200 µL
PRDX6, ID (PRDX6, AOP2, KIAA0106, Peroxiredoxin-6, 1-Cys peroxiredoxin, 24kD protein, Acidic calcium-independent phospholipase A2, Antioxidant protein 2, Liver 2D page spot 40, Non-selenium glutathione peroxidase, Red blood cells page spot 12) (AP) discontinued
Ask
View Details